Abstract
A recently synthesized vanadyl(IV) complex with aspirin[VO(aspirin)ClH2O]2, has been thoroughly investigated by physicochemical techniques. In order to support the proposed structure, stoichiometry and the coordination sphere of the vanadium center, some studies such as elemental analysis, electronic (diffuse reflectance) and vibrational (infrared) spectroscopies, magnetic susceptibility, as well as the thermal behavior, were carried out. The bioactivity of the vanadium complex (VOAspi) was evaluated on two osteoblast-like cell lines in culture, being its cytotoxic effects stronger than the vanadyl cation as assessed by morphological changes and lipid peroxidation. These effects may be partially explained through the induction of the expression of Erks (Extracellular signal-regulated kinases) and the inhibition of the PTPases (Phosphotyrosine phosphatases) present in the cellular extracts.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allegretti Y, Ferrer EG, Gonzales Baró AC, Williams PAM. 2000 Oxovanadium(IV) complexes of quinic acid. Synthesis, characterization and potentiometric study Polyhedron 19, 2613–2619.
Ballhausen CJ, Gray HB. 1962 The electronic structure of the vanadyl ion 1962 Inorg Chem 1, 111–122
Baslas RK, Zamani R, Nomani AA. 1979 Studies on the metal-complex of acetyl salicylic acid (aspirin). Experientia 35, 455–456
Barrio DA, Braziunas MD, Etcheverry SB, Cortizo AM. 1997 Maltol complexes of vanadium(IV) and (V) regulate in vitro alkaline phosphatase activity and osteoblast-like cell growth. J Trace Elements Med Biol 11, 110–115.
Binev IG, Stamboliyska BA, Binev YI. 1996 The infrared spectra and structure of acetylsalicylic acid (aspirin) and its oxoanion; an ab initio force field treatment. J Mol Struct 378, 189–197.
Bradford M. 1976 Rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248–254.
Brown DH, Smith WE, Teape IW, Lewis AJ. 1980 Antiinflamatory effects of some copper complexes. J Med Chem 23, 729–734.
Carvill A, Higgins P, McCann M, Ryan H, Shiels A. 1989 Synthesis, Spectroscopic, Electrochemical, and Magnetic Properties of Dimolybdenum(II,II), Diruthenium-(II,III) and-(II,II) Complexes containing Bridging Aspirinate (2-Acetoxybenzoate) Ligands. J Chem Soc Dalton Trans, 2435–2442
Chasteen ND, ed. 1990 Vanadium in Biological Systems. Dordrecht, The Netherlands: Kluwer Academic Publishers.
Clark RJH. 1973 Vanadium. In: Bailar JC, Emeléns HJ, Nyholm Sir R, Trotman-Dickenson AF, eds. Comprehensive Inorganic Chemistry. Vol. 3. Oxford: Pergamon Press Ltd; 491–551.
Cortizo AM, Bruzzone L, Molinuevo S, Etcheverry SB. 2000a A possible role of oxidative stress in the vandium-induced cytotoxicity in the MC3T3E1 osteoblast and UMR106 osteosarcoma cell lines. Toxicology 147, 89–99.
Cortizo AM, Caporossi M, Lettieri G, Etcheverry SB. 2000b Vanadate-induced nitric oxide production: role in osteoblast growth and differentiation. Eur J Pharmacol 400, 279–285
Cortizo AM, Etcheverry SB. 1995 Vanadium derivatives act as growth factor-mimetic compounds upon differentiation and proliferation of osteoblast-like UMR106 cells. Mol Cell Biochem 145, 97–102
Domingo JL. 2000 Vanadium and diabetes. What about vanadium toxicity? Mol Cell Biochem 203, 185–187.
Etcheverry SB, Cortizo AM 1998. Bioactivity of vanadium compounds in cells in culture In: Nriagu JO, ed. Vanadium in the Enviroment. 15. New York: John Wiley & Sons, Inc.; 359–394
Etcheverry SB, Crans DC, Keramidas AD, Cortizo AM. 1997 Insulin mimetic action of vanadium compounds on osteoblast-like cells in culture. Arch Biochem Biophys 338, 7–14.
Etcheverry SB, Williams PAM, Barrio DA, Sálice VC, Ferrer EG, Cortizo AM. 2000 Synthesis, characterization and bioactivity of a new VO2+/Aspirin complex. J Inorg Biochem 80, 169–171.
Ferrer EG, Williams PA, Baran EJ. 1993 The interaction of the VO2*cation with oxidized glutathione. J Inorg Biochem 50, 253–262.
Goldfine AB, Willsky G, Kahn CR. 1998 Vanadium salts in the treatment of human diabetes mellitus. In: Tracey AS, Crans DC, eds. Vanadium compounds. Chemistry, biochemistry and therapeutic applications 28. ACS Symposium series 711. American Chemical Society, Washington, DC, 353–368.
Gresser MJ, Tracey AS. 1990 Vanadate as phosphate analogs in biochemistry. In: Chasteen ND, ed. Vanadium in Biological Systems. The Netherlands: Kluwer Academic Publisheres; 63–79.
Huyer G, Liu S, Kelly J et al. 1997 Mechanism of inhibition of protein tyrosine phosphatase by vanadate and pervanadate. J Biol Chem 272, 843–851.
Krejsa CM, Nadler SG, Esselstyn JM, Kavanagh TJ, Ledbetter JA, Schieven GL. 1997 Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors. J Biol Chem 272, 11541–11549.
Kögerler P, Ferrer EG, Baran EJ. 1996 Preparation and properties of some salts of the Bis(benzylmalonato)aquaoxovanadium(IV) Anion. Monatsh Chem 127, 801–810.
Laemmli UK. 1970 Cleveage of structural proteins during the assembly of the head of bacteriophage T4. Ann N Y Acad Sci 51, 660–670.
Lever ABP. 1984 Inorganic Electronic Spectroscopy. 2nd edition. Amsterdam: Elsevier.
Li J, Elberg G, Shechter Y. 1996 Phenylarsine oxide and vanadate: apparent paradox of inhibition of protein phosphotyrosine phosphatases in rat adipocytes. Biochim Biophys Acta 1312, 223–230.
Lin-Vien, Colthup NB, Fateley WG, Graselli JG 1991 Infrared and Raman Characteristic Frequencies of Organic Molecules. San Diego: Academic Press.
Nakamoto K. 1997 Infrared and Raman Spectra of Inorganic and Coordination Compounds. Part B. New York: Wiley.
Nielsen FH 1995 Vanadium in mamalian physiology and nutrition In: Siegel H, Siegel A, eds. Vanadium and its role in life 31. New York: Marcell Dekker; 543–573.
Nriagu JO. 1998 History, ocurrence and uses of vandium In: Nriagu JO, ed. Vanadium in the Enviroment. New York: John Wiley & Sons, Inc; 1–24.
Ohkawa H, Ohishi N, Yagi K. 1979 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95, 351–358.
Pandey SK, Theberge JF, Bernier M, Srivastava AK. 1999 Phosphatidylinositol 3-kinase requirement in activation of Ras/c-Raf-1/Mek/Erk and p70 (s6k) signaling cascade by insulin-mimetic agent vanadyl sulfate. Biochemistry 38, 14667–14675.
Posner BI, Faure R, Burgess JW et al. 1994. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin-mimetics. J Biol Chem 269, 4596–4604.
Sálice VC, Cortizo AM, Gó mez Dumm CL, Etcheverry SB. 1999 Tyrosine phosphorylation and morphological transformation induced by for vanadium compounds on MC3T3E1. Mol Cell Biochem 198, 119–128.
Shechter Y. 1990 lnsulin-mimetic effect of vanadate. Possible implications for future treatment of diabetes. Diabetes 39, 1–5.
Sorenson IR. 1982 The anti-inflamatory activities of copper complexes. In: Siegel H, ed. Metal Ions in Biological Systems 14. New York: Marcel Dekker; 77–124.
Srivastava AK, Chiasson J-L eds. 1995 Vanadium compounds: Biochemical and therapeutic Applications. Focused issue in Mol Cell Biochem 153.
Stern A, Yin X, Tsang S-S, Davison A, Moon T. 1993 Vanadium as a modulator of cellular regulatory cascades and oncogene expression. Biochem Cell Biol 71, 103–112
Syamal A. 1975 Spin-spin coupling in oxovanadium(IV) complexes. Coord Chem Rev 16, 309–339.
White MF, Kahn CR. 1994 The insulin signaling system. J Biol Chem 269, 1–4.
Williams PAM, Kögerler P, Baran EJ. 1998 Interaction of the VO2+ cation with suprofen. Acta Farm Bonaerense 17: 31–34
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Etcheverry, S.B., Williams, P.A., Sálice, V.C. et al. Biochemical properties and mechanism of action of a vanadyl(IV) – aspirin complex on bone cell lines in culture. Biometals 15, 37–49 (2002). https://doi.org/10.1023/A:1013183910203
Issue Date:
DOI: https://doi.org/10.1023/A:1013183910203